» Articles » PMID: 5790480

The Use of Antifibrinolytic Substances in Ruptured Intracranial Aneurysms

Overview
Specialty Neurosurgery
Date 1969 May 1
PMID 5790480
Citations 14
Authors
Affiliations
Soon will be listed here.
Citing Articles

Perioperative use of recombinant factor VII to prevent intraoperative aneurysm rupture in high risk patients: a preliminary safety evaluation.

Nussbaum E, Janjua T, Defillo A, Sinner P, Zelensky A Neurocrit Care. 2008; 10(1):55-60.

PMID: 18818887 DOI: 10.1007/s12028-008-9149-9.


The Use of AMICAR(R) in Subarachnoid Hemorrhage.

Van Der Meulen J Calif Med. 1972; 117(5):61-2.

PMID: 18730851 PMC: 1518562.


Letter to the editors of acta neurochirurgica. Management of patients with subarachnoid haemorrhage with tranexamic acid.

Fodstad H, THULIN C Acta Neurochir (Wien). 1980; 54(1-2):127-31.

PMID: 7435290 DOI: 10.1007/BF01401951.


Prevention of recurrence of spontaneous subarachnoid haemorrhage by tranexamic acid.

Gelmers H Acta Neurochir (Wien). 1980; 52(1-2):45-50.

PMID: 7376944 DOI: 10.1007/BF01400945.


Anti-fibrinolytic treatment in the pre-operative management of subarachnoid haemorrhage caused by ruptured intracranial aneurysm.

Ameen A, Illingworth R J Neurol Neurosurg Psychiatry. 1981; 44(3):220-6.

PMID: 7229645 PMC: 490895. DOI: 10.1136/jnnp.44.3.220.